Revolution Medicines Inc RVMD

US Biotechnology

$187.53 ▼ -2.41% ($-4.64)

📅 Earnings This Week

Open $192.00

Prev Close $192.17

Day Range $186.15 – $192.00

52W Range $34.00 – $194.56

Market Cap $39.87B

Beta 1.41

EPS (TTM) $-4.80

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2020-02-13
Shares Out.	212,600,000
Website	revmed.com/ ↗
Phone	13026365400
Employees	883
Net Income	-$453.8M
Free Cash Flow	-$1.07B
Total Assets	$2.25B
Total Liabilities	$753.8M
Equity	$1.50B

About Revolution Medicines Inc

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Revolution Medicines Inc is a publicly traded company under the ticker symbol RVMD on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.